Why did ABT.SW stock spike in volume intraday?

The spike to **40** shares versus an average of **1** likely reflects a concentrated block trade or portfolio rebalancing on the SIX. No simultaneous Abbott press release was found; traders may be positioning ahead of the **2026-04-15** earnings date.

How should traders use the ABT.SW stock volume spike?

Use the spike to identify short-term momentum. Watch **CHF100.00** as intraday support and confirm moves with follow-through volume or a break above **CHF106.00**. Apply tight stops due to thin liquidity on SIX.

What is Meyka AI's view on ABT.SW stock valuation?

Meyka AI assigns a **B+ (73.54/100)** grade. The firm notes a premium PE **34.48** versus sector average and solid cash flow metrics. The grade balances valuation against growth and sector positioning.

What forecasts exist for ABT.SW stock price?

Meyka AI's forecast model projects a **quarterly target CHF109.12** (up **9.12%**) and a **yearly target CHF91.13** (down **-8.87%**) from **CHF100.00**. Forecasts are projections, not guarantees.

CH Stocks

ABT.SW Abbott Laboratories (SIX) volume spike 40x avg: watch CHF100.00 support

ByDanny Kontos February 13, 2026February 13, 2026

Intraday volume for ABT.SW stock spiked to 40 shares, 40.00x the 1-share average on 13 Feb 2026, lifting the price to CHF100.00. The move on the SIX Switzerland tape shows concentrated buying in a thin market and a 1.01% intraday gain. Traders should note the narrow day range (CHF100.00–100.00) and relative volume signal. We use this volume spike to separate short-term momentum from underlying fundamentals and to flag key levels ahead of Abbott’s next earnings date.